Pine Bridge Investments, L.P. Enanta Pharmaceuticals Inc Transaction History

Pine Bridge Investments, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$40.22 - $62.0 $395,644 - $609,894	-9,837 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$57.95 - $66.61 $317,276 - $364,689	-5,475 Reduced 35.76%	9,837 $608,000
Q3 2019 Nov 13, 2019	BUY	$60.08 - $88.17 $76,722 - $112,593	1,277 Added 9.1%	15,312 $920,000
Q2 2019 Aug 13, 2019	BUY	$81.3 - $97.35 $822,349 - $984,695	10,115 Added 258.04%	14,035 $1.18 Million
Q1 2019 May 14, 2019	BUY	$69.08 - $105.66 $4,628 - $7,079	67 Added 1.74%	3,920 $374,000
Q4 2018 Feb 13, 2019	BUY	$65.41 - $84.65 $27,668 - $35,806	423 Added 12.33%	3,853 $273,000
Q3 2018 Nov 13, 2018	BUY	$85.46 - $126.37 $81,528 - $120,556	954 Added 38.53%	3,430 $293,000
Q2 2018 Aug 09, 2018	SELL	$81.85 - $120.51 $32,494 - $47,842	-397 Reduced 13.82%	2,476 $287,000
Q1 2018 May 14, 2018	BUY	$57.91 - $92.15 $166,375 - $264,746	2,873 New	2,873 $232,000
Q4 2017 Feb 09, 2018	SELL	$45.65 - $59.37 $80,891 - $105,203	-1,772 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$37.91 - $46.8 $2,198 - $2,714	-58 Reduced 3.17%	1,772 $82,000
Q2 2017 Aug 11, 2017	BUY	N/A	1,830	1,830 $66,000

108

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.